Floatz logo

Allogeneic Cd34+-Enriched And Cd45Ra-Depleted Pbscs

Myelodysplastic Syndromes

Fred Hutchinson Cancer CenterCell therapyPhase 2/3Active
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
69/ 100
Competitive Position
65/ 100

Competitive context

137 Active assets in the Myelodysplastic Syndromes cohort.

Asset / SponsorPhaseRating
Cytosin-Arabinosid
The First Affiliated Hospital of Soochow University
Phase 4BB
FILGRASTIM
City of Hope Medical Center
Phase 4BB
Daunorubicin
OHSU Knight Cancer Institute
Phase 3BB
Cyclophosphamide
Sawa Ito, MD
Phase 4BB
Romidepsin
Sawa Ito, MD
Phase 4BB

View all 50 →

Same molecule, other indications

Allogeneic Cd34+-Enriched And Cd45Ra-Depleted Pbscs is also rated in:

acute lymphoblastic leukemiaDormant
BBB
Indicative ·
74 / 100
View asset →
Acute Myelogenous LeukemiaDormant
BB
Indicative ·
70 / 100
View asset →
Opportunistic InfectionsDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →